Skip to main content
Clinical Trials/JPRN-UMIN000030510
JPRN-UMIN000030510
Completed
Phase 2

Feasibility of sentinel lymph node biopsy for acquired clinical node-negative breast cancer after neoadjuvant therapy in node-positive breast cancer, multi-centric, single arm, phase II, confirmatory study - Sentinel lymph node biopsy after neoadjuvant therapy in node-positive breast cancer

Osaka City General Hospital0 sites19 target enrollmentDecember 25, 2017
ConditionsBreast cancer

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Breast cancer
Sponsor
Osaka City General Hospital
Enrollment
19
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 25, 2017
End Date
December 31, 2023
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Inoperable case Inflammatory breast cancer Progressive disease after neoadjuvant therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials